Subsidy Information and Financing Scheme MAFSiponimod Tablet 0.25 mg, 2 mg Treatment of adults with secondary progressive multiple sclerosis with active disease evidenced by ... See all × MAFSiponimod Tablet 0.25 mg, 2 mg Treatment of adults with secondary progressive multiple sclerosis with active disease evidenced by relapses or imaging features of inflammatory activity.
Drug Guidance for Subsidy 04/01/2022 Disease-modifying therapies for treating multiple sclerosis The Ministry of Health’s Drug Advisory Committee has recommended: Fingolimod 0.25 mg and 0.5 ... See all × 04/01/2022 Disease-modifying therapies for treating multiple sclerosis The Ministry of Health’s Drug Advisory Committee has recommended: Fingolimod 0.25 mg and 0.5 mg capsules for treating adults and children with relapsing-remitting multiple sclerosis, and Siponimod 0.25 mg and 2 mg tablets for treating adults with secondary progressive multiple sclerosis with active disease evidenced by relapses or imaging features of inflammatory activity. Subsidy status RFingolimod 0.25 mg and 0.5 mg capsules and siponimod 0.25 mg and 2 mg tablets are recommended for inclusion on the Medication Assistance Fund (MAF) for the abovementioned indications. NRMAF assistance does not apply to any formulations or strengths of alemtuzumab, cladribine, dimethyl fumarate, interferon beta-1a, natalizumab, ofatumumab or teriflunomide for treating adults or children with any form of multiple sclerosis.
Post Marketing Information PEM 15/08/2024 Physician’s Checklist*: Important points to remember before, during and after treatment with Mayzent® PMG 27/10/2023 Patient and Caregiver Guide: Important things to remember about your MAYZENT® (siponimod) treatment PAC 15/08/2024 MAYZENT® (siponimod): Information for female patients of childbearing potential
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet 2 mg Singapore General Hospital Tan Tock Seng Hospital Tablet 0.25 mg Singapore General Hospital Tan Tock Seng Hospital
ORAL Select a brand starting with the letter: M MAYZENT FILM-COATED TABLET 0.25MG [SIN16040P] MAYZENT FILM-COATED TABLET 2MG [SIN16039P]